These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11319177)

  • 41. Outdoor artificial light at night and risk of non-Hodgkin lymphoma among women in the California Teachers Study cohort.
    Zhong C; Franklin M; Wiemels J; McKean-Cowdin R; Chung NT; Benbow J; Wang SS; Lacey JV; Longcore T
    Cancer Epidemiol; 2020 Dec; 69():101811. PubMed ID: 33002844
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
    Abuamsha H; Kadri AN; Hernandez AV
    Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The interrelationship between Hodgkin's disease and non-Hodgkin's lymphomas.
    Jaffe ES; Zarate-Osorno A; Kingma DW; Raffeld M; Medeiros LJ
    Ann Oncol; 1994; 5 Suppl 1():7-11. PubMed ID: 8172822
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study.
    Palanca-Wessels MC; Czuczman M; Salles G; Assouline S; Sehn LH; Flinn I; Patel MR; Sangha R; Hagenbeek A; Advani R; Tilly H; Casasnovas O; Press OW; Yalamanchili S; Kahn R; Dere RC; Lu D; Jones S; Jones C; Chu YW; Morschhauser F
    Lancet Oncol; 2015 Jun; 16(6):704-15. PubMed ID: 25925619
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pregnancy and risk of non-Hodgkin's lymphoma: a prospective study.
    Adami HO; Tsaih S; Lambe M; Hsieh C; Adami J; Trichopoulos D; Melbye M; Glimelius B
    Int J Cancer; 1997 Jan; 70(2):155-8. PubMed ID: 9009153
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence of an association between non-Hodgkin's lymphoma and skin cancer.
    Adami J; Frisch M; Yuen J; Glimelius B; Melbye M
    BMJ; 1995 Jun; 310(6993):1491-5. PubMed ID: 7787593
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased metastasis of malignant fibrous histiocytoma in patients with chronic lymphocytic leukemia and non-hodgkin lymphoma.
    Kubica AW; Rose PS; Weaver AL; Brewer JD
    Mayo Clin Proc; 2011 Aug; 86(8):738-43. PubMed ID: 21803956
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blood transfusions as a risk factor for non-Hodgkin's lymphoma in the San Francisco Bay Area: a population-based study.
    Chow EJ; Holly EA
    Am J Epidemiol; 2002 Apr; 155(8):725-31. PubMed ID: 11943690
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prednimustine and mitoxantrone (PmM) in patients with low-grade malignant non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), and prolymphocytic leukemia (PLL).
    Freund M; Wunsch-Zeddies S; Schäfers M; Wysk J; Seidel I; Hiddemann W; Hanauske AR; Link H; Schmoll HJ; Poliwoda H
    Ann Hematol; 1992 Feb; 64(2):83-7. PubMed ID: 1554799
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/Cancer Study Group.
    Coté TR; Biggar RJ; Rosenberg PS; Devesa SS; Percy C; Yellin FJ; Lemp G; Hardy C; Geodert JJ; Blattner WA
    Int J Cancer; 1997 Nov; 73(5):645-50. PubMed ID: 9398040
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Frequency and impact of grade three or four toxicities of novel agents on outcomes of older patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma (alliance A151611).
    Tallarico M; Foster JC; Seisler D; Lafky JM; Hurria A; Jatoi A; Cohen HJ; Muss HB; Bartlett N; Cheson BD; Jung SH; Leonard JP; Byrd JC; Nabhan C
    J Geriatr Oncol; 2018 Jul; 9(4):321-328. PubMed ID: 29673807
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prediagnostic immunoglobulin E levels and risk of chronic lymphocytic leukemia, other lymphomas and multiple myeloma-results of the European Prospective Investigation into Cancer and Nutrition.
    Nieters A; Łuczyńska A; Becker S; Becker N; Vermeulen R; Overvad K; Aleksandrova K; Boeing H; Lagiou P; Trichopoulos D; Trichopoulou A; Krogh V; Masala G; Panico S; Tumino R; Sacerdote C; Bueno-de-Mesquita B; Jeurnink SM; Weiderpass E; Ardanaz E; Chirlaque MD; Sánchez MJ; Sánchez S; Borgquist S; Butt S; Melin B; Späth F; Rinaldi S; Brennan P; Kelly RS; Riboli E; Vineis P; Kaaks R
    Carcinogenesis; 2014 Dec; 35(12):2716-22. PubMed ID: 25269801
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers.
    Levi F; Randimbison L; Te VC; La Vecchia C
    Br J Cancer; 1996 Dec; 74(11):1847-50. PubMed ID: 8956805
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alcohol, smoking, and body size in relation to incident Hodgkin's and non-Hodgkin's lymphoma risk.
    Lim U; Morton LM; Subar AF; Baris D; Stolzenberg-Solomon R; Leitzmann M; Kipnis V; Mouw T; Carroll L; Schatzkin A; Hartge P
    Am J Epidemiol; 2007 Sep; 166(6):697-708. PubMed ID: 17596266
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.
    Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM
    J Clin Oncol; 2015 Oct; 33(28):3096-104. PubMed ID: 26240221
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A phase I/II study examining pentostatin, chlorambucil, and theophylline in patients with relapsed chronic lymphocytic leukemia and non-Hodgkin's lymphoma.
    Willis CR; Goodrich A; Park K; Waselenko JK; Lucas M; Reese A; Diehl LF; Grever MR; Byrd JC; Flinn IW
    Ann Hematol; 2006 May; 85(5):301-7. PubMed ID: 16518606
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overweight and obesity at different times in life as risk factors for non-Hodgkin's lymphoma: the multiethnic cohort.
    Maskarinec G; Erber E; Gill J; Cozen W; Kolonel LN
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):196-203. PubMed ID: 18187389
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Common immune-related risk factors and incident non-Hodgkin lymphoma: the multiethnic cohort.
    Erber E; Lim U; Maskarinec G; Kolonel LN
    Int J Cancer; 2009 Sep; 125(6):1440-5. PubMed ID: 19444913
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Obesity and risk of non-Hodgkin's lymphoma: a meta-analysis.
    Larsson SC; Wolk A
    Int J Cancer; 2007 Oct; 121(7):1564-70. PubMed ID: 17443495
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Occupational risk factors for non-Hodgkin's lymphoma: a population-based case-control study in Northern Germany.
    Richardson DB; Terschüren C; Hoffmann W
    Am J Ind Med; 2008 Apr; 51(4):258-68. PubMed ID: 18213641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.